Edap Tms S.a. EDAP
Set alert
As of Jun 2, 9:30 AM ET
- YTD
- +44.53%
- 1 year
- +168.64%
- Open
- 4.75
- Prev close
- 4.76
- Mkt cap
- 82.37M
- Vol
- 28.86K
- Avg vol
- 161.81K
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.50
- High
- 4.80
- Forward P/E
- -4.72
- Beta
- 0.38
- Short ratio
- 0.22
- Inst. own
- 42.45%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 4.66
- 1y target
- 10.67
2Y chart
Events in this range
- Jul 22, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 28, 2024Earnings: -0.18; estimate -0.14; surprise -28.57%
- Aug 29, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 7, 2024Earnings: -0.19; estimate -0.16; surprise -18.75%
Signals (72)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Jun 1, 2026 | 5 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| RSI: Overbought | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 15, 2026 | 6 months ago |
| SMA: Bearish | Mar 11, 2026 | 7 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 18, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| RSI: Overbought | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 20, 2026 | 9 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Jan 6, 2026 | 9 months ago |
| RSI: Overbought | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Nov 25, 2025 | 11 months ago |
| SMA: Bearish | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 20, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 14, 2025 | 11 months ago |
| SMA: Bullish | Nov 7, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 11 months ago |
| SMA: Bullish | Nov 4, 2025 | 12 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 28, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 28, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 23, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 16, 2025 | 1 year ago |
| SMA: Bullish | Aug 29, 2025 | 1 year ago |
| RSI: Overbought | Aug 28, 2025 | 1 year ago |
| SMA: Bullish | Aug 26, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| RSI: Oversold | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| SMA: Bearish | May 15, 2025 | 1 year ago |
| MACD: Sell Signal | May 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 25, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| RSI: Oversold | Apr 2, 2025 | 1 year ago |
| SMA: Bearish | Mar 11, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| RSI: Overbought | Feb 14, 2025 | 1 year ago |
| SMA: Bullish | Jan 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Jan 8, 2025 | 1 year ago |
| SMA: Bullish | Jan 3, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 17, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 5, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 2, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Oct 31, 2024 | 2 years ago |
| SMA: Bullish | Oct 30, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 4, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 2, 2024 | 2 years ago |
| RSI: Oversold | Oct 2, 2024 | 2 years ago |
| RSI: Oversold | Sep 25, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 11, 2024 | 2 years ago |
| RSI: Oversold | Aug 26, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 9, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 6, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 1, 2024 | 2 years ago |
Key statistics
- Market cap
- 82.37M
- Enterprise value
- 64.67M
- Trailing P/E
- 0.00
- Forward P/E
- -4.72
- PEG ratio
- 0.00
- Price / sales
- 1.30
- Price / book
- 1.94
- EPS (TTM)
- -0.62
- Beta
- 0.38
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -34.88%
- Revenue (TTM)
- 63.41M
- Revenue growth
- 11.60%
- Free cash flow
- -6.42M
- Total cash
- 25.48M
- Total debt
- 8.61M
- Return on equity
- -43.07%
- Shares outstanding
- 37.10M
- Short % of float
- 0.15%
- 50-day average
- 2.53
- 200-day average
- 4.66
Analyst view
Consensus: none
- Target (low)
- 5.00
- Target (mean)
- 10.67
- Target (high)
- 19.00
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.1095.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.16 | -0.19 | -0.03 | -18.75% |
| Aug 28, 2024 | Jun 1, 2024 | -0.14 | -0.18 | -0.04 | -28.57% |
| May 16, 2024 | Mar 1, 2024 | -0.10 | -0.13 | -0.03 | -30.00% |
| Mar 27, 2024 | Dec 1, 2023 | -0.02 | -0.15 | -0.13 | -650.00% |
| Nov 9, 2023 | Sep 1, 2023 | -0.11 | -0.12 | -0.01 | -9.09% |
| Aug 24, 2023 | Jun 1, 2023 | -0.03 | -0.14 | -0.11 | -366.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 29, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 22, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 17, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Apr 1, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 10, 2023 | Piper Sandler | main | Overweight | Overweight |
| Aug 25, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
About Edap Tms S.a.
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- France
- Website
- edap-tms.com
News
- EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript
- McDonald's Corp (MCD) (Q2 2026) Earnings Call Highlights: Navigating US Execution Challenges While Driving Global Growth
- Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion
- EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
- Telix Pharma Enters Into LOI To Pursue Collaborations With EDAP And Profound Medical To Explore Investigational Use Of Telix's PSMA-PET1 Imaging Agents Gozellix And Illuccix With Robotic HIFU, And Other Image-Guided Therapies To Treat Prostate Cancer
- EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
- EDAP | Focal One to Host Investor Day on June 1, 2026
- EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript
- EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue
Your note
Sign in to keep a note on EDAP — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Soleus Capital Management, L.P. | 19.70% | 7,309,254 | 16.23M | Sep 29, 2024 |
| Morgan Stanley | 9.08% | 3,369,770 | 7.48M | Sep 29, 2024 |
| Rock Springs Capital Management, LP | 4.23% | 1,568,000 | 3.48M | Sep 29, 2024 |
| Archon Capital Management LLC | 2.86% | 1,060,881 | 2.36M | Sep 29, 2024 |
| Bruce & Co, Inc. | 1.49% | 553,652 | 1.23M | Sep 29, 2024 |
| Apis Capital Advisors, LLC | 1.46% | 540,000 | 1.20M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bruce & Co., Inc. | 1.43% | 529,794 | 1.18M | Sep 29, 2024 |
| Federated Hermes Kaufmann Fund | 1.06% | 395,002 | 876.90K | Jul 30, 2024 |
| Federated Hermes Kaufmann Small Cap Fund | 1.06% | 395,002 | 876.90K | Jul 30, 2024 |
| Trust for Professional Managers-ActivePassive International Equity ETF | 0.07% | 26,646 | 59.15K | Aug 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 22,764 | 50.54K | Oct 30, 2024 |
| Federated Hermes Kaufmann Fund II | 0.01% | 4,125 | 9.16K | Sep 29, 2024 |